Back to News

Chardan 4th Annual Genetic Medicines Conference – Virtual

Bernard Gilly, co-Founder and CEO, will present the company on October 6, 2020 at 8.00am EST (2.00pm CEST). A fireside chat with research analyst Gbola Amusa will take place. The live webcast of the chat can be accessed by clicking here.

The webcast replay will be available for at least 72 hours following the live event.

Members of GenSight’s executive team will participate in virtual one-on-one investor meetings throughout the event.

 

Back to News

A New Chapter

Founded in 2012 to realize the potential of gene therapy, GenSight Biologics has grown into a clinical-stage company advancing multiple programs. In 2024, under a new management team, the company entered a new phase and is now accelerating its clinical and regulatory activities.

Explore investors’ hub

GenSight Biologics S.A.
74 rue du Faubourg Saint-Antoine
75012 Paris
France